Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IRD alerts

About Dr. George Magrath

Dr. George Magrath is recorded as Board Member and CEO at Opus Genetics, Inc. (IRD). The newest filing on record that lists Dr. George Magrath as Board Member and CEO at Opus Genetics, Inc. (IRD) is dated March 23, 2026. The proxy statement of Opus Genetics, Inc. reports total compensation of $1,493,383 for Dr. George Magrath in fiscal 2025, including a base salary of $598,000. Disclosed compensation is on record for 3 fiscal years. Dr. George Magrath has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on September 9, 2026. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member), Richard Rodgers (CEO and Board Member) and 7 others.

Dr. George Magrath on recent calls

“We are excited to share the current results from Cohort 1 and our BEST 1-2 clinical trial known as BIRD-1, which exceeded our expectations from this first in human cohort.”
CEO, OPGx-BEST1 Cohort 1 Data Conference Call ·

Affiliation history

Company network

Leadership on record at Opus Genetics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Opus Genetics, Inc. (IRD) $598,000 $1,493,383
2024 Opus Genetics, Inc. (IRD) $575,000 $889,238
2023 Opus Genetics, Inc. (IRD) $95,833 $2,667,353

Recent activity